Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Total Debt (2016 - 2025)

Veracyte (VCYT) has disclosed Total Debt for 14 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Total Debt fell 92.16% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 92.16% year-over-year, with the annual reading at $1.3 million for FY2025, 92.16% down from the prior year.
  • Total Debt hit $1.3 million in Q4 2025 for Veracyte, down from $13.6 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $17.0 million in Q4 2024 to a low of $1.1 million in Q2 2022.
  • Historically, Total Debt has averaged $6.1 million across 5 years, with a median of $4.0 million in 2021.
  • Biggest five-year swings in Total Debt: surged 815.64% in 2021 and later tumbled 92.16% in 2025.
  • Year by year, Total Debt stood at $2.7 million in 2021, then surged by 125.95% to $6.1 million in 2022, then plummeted by 56.16% to $2.7 million in 2023, then surged by 539.1% to $17.0 million in 2024, then plummeted by 92.16% to $1.3 million in 2025.
  • Business Quant data shows Total Debt for VCYT at $1.3 million in Q4 2025, $13.6 million in Q3 2025, and $13.4 million in Q2 2025.